JD

James R. Dasch

CP Celtrix Pharmaceuticals: 4 patents #8 of 42Top 20%
AT Alkermes Controlled Therapeutics: 2 patents #26 of 48Top 55%
AL Alkermes Pharma Ireland Limited: 1 patents #80 of 116Top 70%
GE Genzyme: 1 patents #498 of 891Top 60%
Overall (All Time): #517,903 of 4,157,543Top 15%
10
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
8129339 Microencapsulation and sustained release of biologically active polypeptides Henry R. Costantino, Joyce M. Hotz, M. Gary I. Riley, Paul A. Burke, Susan A. Steitz-Abadi +1 more 2012-03-06
7074432 Method of modifying the release profile of sustained release compositions M. Gary I. Riley 2006-07-11
6558702 Method of modifying the release profile of sustained release compositions M. Gary I. Riley 2003-05-06
6419928 Monoclonal antibodies to transforming growth factor-beta and methods of use Doran R. Pace, III, Wendy Waegell 2002-07-16
6090383 Monoclonal antibodies to transforming growth factor-.beta. and methods of use Doran R. Pace, III, Wendy Waegell 2000-07-18
5783185 Monoclonal antibodies to transforming growth factor-beta and methods of use Doran R. Pace, III, Wendy Waegell 1998-07-21
5772998 Monoclonal antibodies to transforming growth factor-beta and methods of use Doran R. Pace, III, Wendy Waegell 1998-06-30
5693607 Uses of TGF-.beta. receptor fragment as a therapeutic agent Patricia R. Segarini, David R. Olsen, Pedro A. Carrillo, Desmond Mascarenhas 1997-12-02
5571714 Monoclonal antibodies which bind both transforming growth factors .beta.1 and .beta.2 and methods of use Doran R. Pace, III, Wendy Waegell 1996-11-05
5462925 Transforming growth factor .beta.2,3 Yasushi Ogawa, David Schmidt 1995-10-31